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Objective: To investigate the impact of the preinduced intestinal heat shock protein 70
(HSP70) on the visceral hypersensitivity and abnormal intestinal motility in a post-
infectious irritable bowel syndrome (PI-IBS) mouse model.
Methods: Eighty-four female C57BL/6 mice were randomly assigned to four groups:
control group (n = 21) and induction + PI-IBS group (n = 21), PI-IBS group (n = 21) and
induction group (n = 21). The mice in PI-IBS group were infected in vivo with Trichinella
spiralis by oral administration. The visceral hypersensitivity and intestinal motility were
evaluated respectively with abdominal withdrawal reﬂex and colon transportation test.
The intestinal HSP70 protein and mRNA level was measured by Western blot and real-
time PCR. Meanwhile, the intestinal proinﬂammatory cytokines IL-10 and TNF-a level
was detected by ELISA.
Results: Compared with their counterparts in PI-IBS group, the animals in the
Induction + PI-IBS group show signiﬁcantly increased intestinal level of HSP70 and
obviously ameliorative clinical ﬁgures, including abdominal withdrawal reﬂex score,
intestine transportation time and Bristol scores (P < 0.05). Meanwhile, the intestinal post-
inﬂammatory cytokines remarkably changed, including increased IL-10 level and
decreased TNF-a level (P < 0.05).
Conclusions: Intestinal HSP70 may play a potential protective role through improving
the imbalance between the intestinal post-inﬂammatory and anti-inﬂammatory cytokines
in PI-IBS.1. Introduction
As a kind of clinical syndrome characterized by abdominal
pain, discomfort and bloating accompanied with abnormal
defecation, the precise pathological mechanism of irritable
bowel syndrome (IBS) remains unclear [1–3]. During the last two
decades, abundant clinical and experimental research focused on
the role of infection and inﬂammation in the pathogenesis of
IBS, called as post-infectious irritable bowel syndrome (PI-
IBS) [4–6]. Recently, it was reported that heat shock protein 70(HSP70) has an unique capability of regulating the protein
misfolding, aggregation and serves critical roles in some
diseases [7,8]. Thus the aim of the current study is to
investigate the potential role of HSP70 in PI-IBS.
2. Materials and methods
Eighty-four female 57BL/6 mice with (6–8) weeks and (13–
15) g were purchased from Kunming Institute of Zoology,
Chinese Academy of Science. All animals were housed in
sterile, pathogen-free, temperature controlled facility on normal
12-h light/dark cycle, and standard diet and water were provided
ad libitum. The experiment was carried out in accordance with
the Chinese guidelines for animal welfare. Experimental proto-
col was approved by the Animal Care and Use Committee of the
Hainan Provincial General Hospital. The animals were randomly
assigned into four groups: control group, induction + PI-IBSs article under the CC BY-NC-ND license
Table 1
HSP70 protein and mRNA level in heat pretreated PI-IBS mice (n = 7).
Group (n = 7) Protein level mRNA level
Control 0.27 ± 0.04 0.44 ± 0.04
PI-IB 0.66 ± 0.04 0.76 ± 0.05
Induction + PI-IBS 1.03 ± 0.06a 1.22 ± 0.10b
Induction 0.33 ± 0.07 0.57 ± 0.06
a Compared with the control group, P < 0.05. b Compared with the PI-
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In each group, 7 mice were sacriﬁced for the detection of the
intestinal HSP70 protein level and 7 mice for that of the intes-
tinal HSP70 mRNA level. The other 7 mice were examined for
the visceral hypersensitivity and the intestinal motility. Trichi-
nella spiralis (T. spiralis) were purchased from Lanzhou Animal
Medical Institute.
2.1. Main reagents
Pepsin (Invitrogen Corporation, U.S.A); histochemistry and
Western blot agents (Wuhan Boster Corporation, China); anti-
bodies (BDBioscience Co., U.S.A).
2.2. Modeling of PI-IBS
The mice were infected with T. spiralis as described previ-
ously [9]. Brieﬂy, the Trichinella spirali lavace were separated
from Sprague–Dawley rats 60 d after infection of Trichinella
spirali's cryst by digestion with 1.5% gastric pepsin. The mice
were fed with the lavarce in 0.2 mL saline (300 lavarce per
mouse). The animals in the control group were fed with only
0.9% saline.
2.3. Abdominal withdrawal reﬂex (AWR)
AWR was used to evaluate the visceral hypersensitivity [10].
The anesthetized animals were inserted via their anus with air
chamber and catheter. The air chamber was distended at
volume of 0.25/0.5/0.75 mL × 15 min × 3 times. Between
each distending time, the animals were permitted to have a
rest for 30 s. The AWR scoring standard: when stimulated, the
animals are in stable mood, 0 point; if the animals are in
unstable mood, twisting their heads once in a while, 1 point;
slightly contracting their abdomen and back muscles, 2 points;
intensively contracting their abdomen muscles and uplifting
the abdomen from the ground, 3 points; intensively
contracting abdomen muscles, bowing abdomen and uplifting
the abdomen and perineum, 4 points.
2.4. Colon transportation test
Colon transportation test was used to evaluate the status of
the intestinal motility. After ﬁlled into stomach with 0.4 mL
active carbon, the ﬁrst black stool time was recorded. The total
stool within 8 h was collected and evaluated by Bristol stool
grade [11]: normal shaped stool, 1 point; soft or deformed stool, 2
points; water-like stool, 3 points.
2.5. Preinduction of HSP70
Expression of HSP70 in mice was induced by heat treatment
according to previous reports [12]. Brieﬂy, mice were
anesthetized with sodium pentobarbital (50 mg/kg). Rectal
temperature was monitored with a thermistor inserted into the
rectum in a baking oven with constant temperature 50 C.
After the body temperature was maintained at 41 C for
20 min, the mice were return to their cages at room
temperature and allowed water and food ad libitum.
Nonheated mice were only anesthetized but received no
hyperthermic stress.2.6. Determination of intestinal HSP70
HSP70 protein level and mRNA expression was measured by
Western blot and real-time PCR respectively. The tissue sample
was grinded and cracked with RIPA. The homogenate was
centrifuged for 30 min. The protein concentration in the super-
natants was measured by Bradford Assay. Tissue sample of 40 g
was separated by SDS page gel electrophoresis and transferred
to the PVDF membrane. The membrane was blotted with TBST
for 1 h, then was added with goat-anti-mouse HSP70 multiple
clone antibodies (1:1000) and rabbit-anti-mouse b-actin multi-
ple clone antibodies (1:1000) at 4 C for 12 h. One day later, the
membrane was washed in TBST and autographied by ECL
chemiluminescent assay. The gray-scale value of HSP70/b-actin
represented the relative expression level of HSP70.
Total RNA was isolated from the terminal ileum tissue with
Trizol liquid and treated with DNAaseI. Primer was designed
according to mouse gene sequence. b-actin was used as an in-
ternal control.
HSP70 gene primer: F: 50-GAAGGTGCTGGACAAGTGC-
30 [(1903–1921) bp, R: 50-GCCAGCAGAGGCCTCTAATC-30
(2120–2139) bp]. b-actin gene primer (470 bp): F: 50-
AGGCTGTGCTGTCCCTGTATG-30, 50-GAGGTCTTTACG-
GATGTCAACG-30.
Real-time PCR was operated with following protocol: 1. Pre-
denaturation program (5 min at 94 C); 2. Denaturation program
(1 min at 94 C); 3. Ampliﬁcation and qualiﬁcation program,
repeated 30 cycles (50 s at 57 C, 20 s at 60 C); 4. Prolonging
program (7 min at 72 C). The relative expression was expressed
as a ratio of the target gene to the control gene.
2.7. Determination of proinﬂammatory cytokines
The tissue sample was ultrasonically shivered and centri-
fuged at 4 C. The concentration of cytokines IL-10 and TNF-a
in the supernatants was measured by ELISA.
2.8. Statistics analysis
Datawere analyzed usingStudent's t-test (SPSS17.0 software).
Data were expressed as the mean ± SE. Values in the same row
with different superscripts are signiﬁcant (P < 0.05), while values
with same superscripts are not signiﬁcantly different (P > 0.05).
3. Results
3.1. Expression of intestinal HSP70
Western blot and RT-PCR show that the intestinal HSP70
protein and mRNA level in Induction + PI-IBS mice was far
more than that in PI-IBS mice (P < 0.05) (Table 1).IBS group, P < 0.05.
Table 2
AWR score in heat pretreated PI-IBS mice.
AWR score
Group (n = 7) Distending air volume (mL)
0.25 0.35 0.5 0.65
Control 0.00 ± 0.00 1.43 ± 0.53 2.57 ± 0.53 3.57 ± 0.53
PI-IBS 0.00 ± 0.00 2.57 ± 0.53 3.57 ± 0.53 3.71 ± 0.49
Induction + PI-
IBS
0.00 ± 0.00 2.14 ± 0.38a 2.71 ± 0.49b 3.86 ± 0.38
Induction 0.00 ± 0.00 1.14 ± 0.69 1.86 ± 0.69 3.71 ± 0.49
a Compared with the PI-IBS group, P < 0.05. b Compared with the PI-
IBS group, P < 0.05.
Table 3
Changes of the intestinal mobility in heat pretreated PI-IBS mouse.
Group First black stool time
(min)
Bristol stool
grade
Control (n = 7) 104.30 ± 11.05 0.97 ± 0.10
PI-IBS (n = 7) 67.97 ± 5.94 2.76 ± 0.42
Induction + PI-IBS
(n = 7)
86.74 ± 5.90a 2.07 ± 0.19b
Induction (n = 7) 101.42 ± 12.38 1.05 ± 0.12
a Compared with the PI-IBS group, P < 0.05. b Compared with the PI-
IBS group, P < 0.05.
Figure 2. Intestinal TNF-a level in heat-pretreated PI-IBS mouse. a:
compared with the control group, P < 0.05; b: compared with the PI-IBS
group, P < 0.05.
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At the distending air volume of 0.25 mL and 0.65 mL, there
was no signiﬁcant difference between the AWR score of the
Induction + PI-IBS mice and the PI-IBS mice (P > 0.05); but at
the distending air volume of 0.35 mL and 0.5 mL, the AWR
score of Induction + PI-IBS mice was obviously lower than that
of PI-IBS mice (P < 0.05) (Table 2).
3.3. Intestinal motility
The colon transport time of the mice in Induction + PI-IBS
group was signiﬁcantly longer than that of the mice in the PI-
IBS group (P < 0.05); the Bristol score of the 8 h stool from
the PI-IBS mice was obviously less than their counterparts in
Induction + PI-IBS group (P < 0.05) (Table 3).
3.4. Expression of intestinal proinﬂammatory cytokines
The intestinal post-inﬂammatory cytokines remarkably
changed, with decreased IL-10 level and increased TNF-a level
(P < 0.05) (Figure 1 and Figure 2).Figure 1. Intestinal IL-10 level in heat-pretreated PI-IBS mouse. a:
compared with the control group, P < 0.05; b: compared with the PI-IBS
group, P < 0.05.4. Discussion
With high incidence rate and refractory history, IBS seriously
impact the patients' life quality, exerting a huge burden on the
patients. There is no effective therapy for this kind of disease up
to now [13].
It has been proved that IBS results from a synergy of multiple
etiological factors including the visceral hypersensitivity, the
abnormal intestinal motility, local immune response and social-
psychological factors [14–17]. Recently, researches mainly focus
on two aspects: the neuropeptides induced visceral
hypersensitivity and abnormal intestinal motility, the low
grade intestinal inﬂammation and continuous immune
activating process. The concept of PI-IBS was considered as
concurs [6,18,19]. The current study was to investigate the role of
the intestinal mucosa immune system using a T. spiralis infected
mice model.
HSP70 is a kind of chaperons whose structures remain un-
changed, structurally expressed or induced by heat shock,
trauma and other stress stimulation. HSP70 could help the
essential proteins to refold their structure, whose folding struc-
ture were changed by the stress and inﬂammatory injure, thus
ﬁxed the lesion [17]. Furthermore, the inﬂammatory cells
expressing HSP70 could be recognized and eradiated by
immunocytes [18,19]. PI-IBS is regarded as a disorder induced
by the intestinal infection and inﬂammation. Our previous study
found that the intestinal HSP70 level increased during PI-IBS.
Thus HSP70 could exert a negative modulating role in PI-IBS.
In the current study, heat pre-treatment signiﬁcantly increased
the intestinal HSP70 level in normal mice, but did not induced
viceroy hypersensitivity and abnormal intestinal motility. Inter-
estingly, heat pre-treatment up-regulated the increasing HSP70
level in PI-IBS mice. Simultaneously, viceroy hypersensitivity
and abnormal intestinal motility in PI-IBS were improved after
heat pretreatment. These results suggest that HSP70 could pro-
tect mice against PI-IBS. On the other hand, heat pre-treatment
could not wholly reverse the clinical symptoms, suggesting that
there could be other pathway through which PI-IBS occurred.
Furthermore, the inﬂammatory cytokines level was detected
to explain how HSP70 exerted its impact on the intestinal
inﬂammation during PI-IBS. IL-10 was a kind of cytokine
inhibiting inﬂammation [20]. TNF-a was considered as an
important pro-inﬂammatory cytokines in some intestinal in-
ﬂammatory diseases [21]. We found that during PI-IBS, the IL-10
level decreased and the TNF-a increased signiﬁcantly. Whereas
preinduction of HSP70 obviously improved the changes of these
cytokines. These results suggest that HSP70 could exert its
protective role via pro-inﬂammatory cytokines pathway.
In conclusion, our results indicated that preinduction of
HSP70 could protect the mice against PI-IBS via improving the
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ﬁnding could help to optimize the treatment for PI-IBS, although
the precise underlying cellular and molecular mechanism of the
regulation remains to be explored.
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